Curaleaf Expands Its Presence by Joining FTSE Canada All Cap Index

Curaleaf Added to the FTSE Canada All Cap Index

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a prominent international name in cannabis consumer products, has recently announced its inclusion in the FTSE Canada All Cap Index, effective after trading on September 18, 2026. This significant development marks yet another milestone for Curaleaf, following its prior inclusion in the SP/TSX Composite Index.

Boris Jordan, Chairman and CEO of Curaleaf, expressed his enthusiasm for this achievement, indicating that it represents a new phase for the company in the Canadian market. “Joining the FTSE Canada All Cap Index now puts Curaleaf in a second major Canadian benchmark. Every index we join brings our shares in front of a new set of passive and active institutional funds, which means more liquidity, a broader shareholder base, and more investors paying attention to what U.S. cannabis can be.”

The FTSE Canada All Cap Index, managed by FTSE Russell, serves as a comprehensive benchmark for the performance of Canadian companies across various capitalizations, including large, mid, and small-cap firms. For Curaleaf, this is a notable advancement as it continues to highlight its growth trajectory within the cannabis industry.

In September 2025, Curaleaf was recognized as the first U.S.-based cannabis operator to be included in the SP/TSX Composite Index under the health care sector. This recent addition into another significant index indicates the company's strategic efforts to solidify its status and expand its market share in Canada.

Curaleaf is renowned for its diverse range of cannabis products and has positioned itself as a leader in the industry, driven by a mission to enhance lives through the power of the cannabis plant. Their extensive list of brands, including the likes of Select, Grassroots, and Dark Heart, allows them to cater to both medical and adult-use markets, ensuring that they deliver quality and reliability to their customers.

The company operates across a broad spectrum of the supply chain, which empowers its international reach across Europe, Canada, and Australasia. This unique distribution network combines pioneering scientific research with cutting-edge cultivation and production processes, which is essential in ensuring compliance and quality in the ever-evolving cannabis market.

With Curaleaf now part of two major indices, the company eyes a future filled with potential increased investment opportunities as institutional funds start to circulate its stock more widely. In turn, this influx of funding is anticipated to further bolster Curaleaf's expansion strategies.

Investors and stakeholders alike are keenly watching how Curaleaf will utilize this momentum moving forward. As cannabis continues to gain acceptance both socially and legally across more regions, Curaleaf is poised to remain at the forefront of this dynamic industry.

As the cannabis landscape evolves, the inclusion of companies like Curaleaf in major market indices signifies a maturation of the cannabis sector, providing more credibility and visibility. This, coupled with the company’s commitment to quality and innovation, places Curaleaf in a favorable position to capitalize on future growth opportunities. With their ongoing efforts to enhance shareholder value and increase market penetration, all eyes will be on Curaleaf as they navigate the next stages of their journey in the cannabis industry.

For more information regarding Curaleaf and their ongoing developments, visit their official site at Curaleaf Holdings.